<DOC>
	<DOC>NCT00747253</DOC>
	<brief_summary>The main purpose of this study is to evaluate the safety and performance of the AutoLITT system for the treatment of recurrent/progressive glioblastoma multiforme tumors (GBM).</brief_summary>
	<brief_title>Monteris AutoLITTâ„¢ FIM Safety Trial for Recurrent/Progressive Brain Tumors</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<criteria>Previous diagnosis of GBM treated with radiotherapy with or without surgical resection and/or chemotherapy Clinical/radiographic suspicion of tumor recurrence/progression Previous treatment of target GBM with stereotactic radiosurgery, brachytherapy, or carmustine impregnated wafers (Gliadel).</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>laser interstitial thermal therapy</keyword>
	<keyword>laser therapy</keyword>
	<keyword>thermal therapy</keyword>
	<keyword>brain tumors</keyword>
	<keyword>recurrent brain tumor</keyword>
	<keyword>progressive brain tumor</keyword>
	<keyword>glioblastoma multiforme tumor</keyword>
</DOC>